Showing results (271-280 of 437) with videos related to

Sort By:
Pageof 44
Pituitary|June 7, 2024
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance studyDario De Alcubierre, Tiziana Feola, Alessia Cozzolino, et al.
Neurological Research|September 25, 2003
Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in ratsJ C de la Torre, B A Pappas, V Prevot, et al.
International Journal of Molecular Sciences|April 25, 2020
PDE2A Is Indispensable for Mouse Liver Development and HematopoiesisFederica Barbagallo, Valentina Rotilio, Maria Rita Assenza, et al.
European Radiology|July 9, 2004
Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn's syndrome)R K Lingam, S A Sohaib, A G Rockall, et al.
European Journal of Endocrinology|December 4, 2003
Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomographyA G Rockall, S A Sohaib, D Evans, et al.
Clinical Endocrinology|December 3, 2019
Thyroid disorders in programmed death 1 inhibitor-treated patients: Is previous therapy with tyrosine kinase inhibitors a predisposing factor?Emilia Sbardella, Marta Tenuta, Grazia Sirgiovanni, et al.
Annals of Medicine|February 6, 2026
Endocrinological aspects of sarcopenic obesityMarianna Minnetti, Eleonora Poggiogalle, Francesco Frigerio, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndromeAndrea M Isidori, Gregory A Kaltsas, Shahid Mohammed, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's diseaseA M Isidori, G A Kaltsas, M Korbonits, et al.
Frontiers in Endocrinology|February 27, 2014
Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectivesRoberto Baldelli, A Barnabei, L Rizza, et al.
Pageof 44